Skip to main
GOCO
GOCO logo

GoHealth, Inc. (GOCO) Stock Forecast & Price Target

GoHealth, Inc. (GOCO) Analyst Ratings

Based on 1 analyst ratings
Hold
Strong Buy 0%
Buy 0%
Hold 100%
Sell 0%
Strong Sell 0%

Bulls say

GoHealth Inc. has demonstrated strong financial growth, with total submissions increasing by 40.2% year-over-year, reaching 303,000, surpassing estimates due to a significant 64% growth in captive Medicare submissions. The company's revenue for the first quarter of 2025 increased by 19.1% year-over-year to $221 million, exceeding both estimates and consensus figures. Additionally, the stabilization of membership persistency and lifetime value (LTV) amidst a rationalized industry marketing spend suggests a more sustainable growth trajectory for GoHealth's operations.

Bears say

GoHealth Inc. has experienced a notable decline in revenue per sale, which decreased by 15.4% to $724, primarily attributed to a mix shift from non-agency to agency submissions. Despite reporting an adjusted EBITDA of $42.1 million for Q1 2025, reflecting a 56.4% year-over-year improvement, concerns remain regarding persistency headwinds, which could lead to negative tail-revenue and lower cash received from commissions. Additionally, the company's valuation may face downward pressure, with estimates suggesting adjusted EBITDA could be approximately 25% lower than the base case scenario, potentially compressing its valuation multiple to around 6.0x.

GoHealth, Inc. (GOCO) has been analyzed by 1 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 100% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GoHealth, Inc. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GoHealth, Inc. (GOCO) Forecast

Analysts have given GoHealth, Inc. (GOCO) a Hold based on their latest research and market trends.

According to 1 analysts, GoHealth, Inc. (GOCO) has a Hold consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GoHealth, Inc. (GOCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.